UroGen Pharma Ltd. announced the appointments of Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs. Mr. Ottinger and Mr. Bova will report to Ron Bentsur, Chief Executive Officer of UroGen Pharma, and will be based in UroGen Pharma’s New York office. Bova joins UroGen Pharma after 20 years at Bayer Healthcare, where he held multiple senior-level sales leadership positions of increasing responsibility. Most recently at Bayer, Mr. Bova served as Vice President of Oncology Sales where he led over 200 field-facing sales representatives marketing well-known brands including Xofigo®, Stivarga® and Nexavar®. Prior to joining UroGen Pharma, Mr. Ottinger served as Senior Vice President of Global Regulatory Affairs at Teva Pharmaceutical Industries Inc.